Results 161 to 170 of about 3,407,912 (356)
A new potential radiosensitizer: ammonium persulfate modified WCNTs [PDF]
, 2007 Radiotherapy plays a very important role in cancer treatment. Radiosensitizers have been widely used to enhance the radiosensitivity of cancer cells at given radiations.
Bo-Zhang Yu, Jian-She Yang, Wen-Xin Li
core +1 more source
From Cell Death to Regeneration: Rebuilding After Injury [PDF]
, 2021 Dylan J. Guerin +2 more
openalex +1 more source
Molecular Oncology, EarlyView.A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Molecular Oncology, EarlyView.Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
TMBIM6 INHIBITS APOPTOSIS OF VULNERABLE NEURONS IN PARKINSON´S DISEASE
IBRO Neuroscience Reports, 2023 Pablo Ahumada Montalva +7 more
doaj +1 more source
EXTH-11. HISTONE DEACETYLASE 6 (HDAC6) INHIBITORS RETARD CELL PROLIFERATION AND INDUCE ROBUST CELL DEATH IN GLIOBLASTOMA (GBM) CELLS AND GBM SPHEROIDS CONTAINING STEM CELLS [PDF]
, 2016 M. Reza Saadatzadeh
openalex +1 more source
Molecular Oncology, EarlyView.Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway
Molecular Oncology, EarlyView.Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed +10 more
wiley +1 more source